AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Esophageal Carcinoma

Open on HERB 2.0 ↗
6
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT01142388
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Active_Not_Recruiting · Phase 2
NCT01366144
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Active_Not_Recruiting · Phase 1
NCT01097304
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Esophageal Carcinoma
🏥 Names
Disease Name
Esophageal Carcinoma
Alias Names
Esophageal Carcinoma; Esophageal Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Digestive System Diseases; Neoplasms
HPO Class
Neoplasm; Abnormality of the digestive system
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
HERB DB
HBDIS003648 ↗
OMIM
133239 ↗
HPO
HP:0011459 ↗
Disease Ontology
5041; 1107
DisGeNET
C0152018
🔍 Raw view — every non-empty column on this row (29 fields)
name
Esophageal Carcinoma
alias name
Esophageal Carcinoma; Esophageal Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Digestive System Diseases; Neoplasms
hpo disease class
Neoplasm; Abnormality of the digestive system
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C06
hpo disease class id
HP:0025031; HP:0002664
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS003648
disgenet id
C0152018
hpo id
HP:0011459
do id
5041; 1107
omim id
133239

⚗️ Related Ingredients

2 · shared evidence
Taxol
Ursodeoxycholic acid

📋 Clinical Trials

6 · subject of clinical study
NCT01142388 Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patien
→ Metastatic Esophageal Adenocarcinoma|Metastatic Es
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors Th
→ Breast Carcinoma|Carcinoma of Unknown Primary|Endo
NCT01097304 Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
→ Barrett Esophagus|Esophageal Carcinoma
NCT02564263 Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy f
→ Esophageal Carcinoma|Esophagogastric Junction Carc
NCT03933449 Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy fo
→ Esophageal Carcinoma|Esophagogastric Junction Carc
NCT02861690 Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent E
→ Esophageal Carcinoma
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables